Jushi (JUSHF) Stock Price, News & Analysis

Company Overview

Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands. It is also involved in the bulk wholesale of refined cannabinoids and terpenes. In addition, the company operates medical cannabis dispensaries under the BEYOND/HELLO, Nature's Remedy, and NuLeaf brands. It markets its products to local dispensaries and large multi-state operators. The company is headquartered in Boca Raton, Florida.

Key Stats

• Today's Range: $0.30 to $0.37
• 50-Day Range: $0.35 to $0.57
• 52-Week Range: $0.22 to $1.09
• Volume: 193,399 shs
• Average Volume: 265,849 shs
• Market Capitalization: $63.31 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Hold

Jushi Stock Analysis - MarketRank™

Jushi scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Jushi.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Jushi are expected to grow in the coming year, from ($0.21) to ($0.16) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Jushi is -1.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Jushi is -1.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

1.02% of the outstanding shares of Jushi have been sold short.

Short Interest Ratio / Days to Cover

Jushi has a short interest ratio ("days to cover") of 5.6.

Change versus previous month

Short interest in Jushi has recently increased by 2.04%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Jushi does not currently pay a dividend.

Dividend Growth

Jushi does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.02% of the outstanding shares of Jushi have been sold short.

Short Interest Ratio / Days to Cover

Jushi has a short interest ratio ("days to cover") of 5.6.

Change versus previous month

Short interest in Jushi has recently increased by 2.04%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 0.8 / 5
• News Sentiment: -0.63

News Sentiment

Jushi has a news sentiment score of -0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Jushi this week, compared to 1 article on an average week.

Search Interest

Only 1 people have searched for JUSHF on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Jushi insiders have not sold or bought any company stock.

Percentage Held by Insiders

21.66% of the stock of Jushi is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 21.68% of the stock of Jushi is held by institutions.

JUSHF Stock Analysis - Frequently Asked Questions

How have JUSHF shares performed this year?

Jushi's stock was trading at $0.46 at the start of the year. Since then, JUSHF shares have decreased by 30.0% and is now trading at $0.3220.
View the best growth stocks for 2024 here.

How were Jushi's earnings last quarter?

Jushi Holdings Inc. (OTCMKTS:JUSHF) announced its quarterly earnings data on Thursday, November, 7th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by $0.04. The firm earned $61.61 million during the quarter, compared to analysts' expectations of $65.53 million. Jushi had a negative net margin of 20.93% and a negative trailing twelve-month return on equity of 5,529.11%.

How do I buy shares of Jushi?

Shares of JUSHF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

• Last Earnings: 11/07/2024
• Today: 11/21/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medicinals & botanicals
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:JUSHF
• CUSIP: N/A
• CIK: 1909747
• Web: www.jushico.com
• Phone: 561-617-9100
• Fax: N/A
• Employees: 1,188
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.27)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-65,100,000.00
• Net Margins: -20.93%
• Pretax Margin: -8.16%
• Return on Equity: -5,529.11%
• Return on Assets: -10.45%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.17
• Quick Ratio: 0.58

Sales & Book Value

• Annual Sales: $269.45 million
• Price / Sales: 0.26
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.20) per share
• Price / Book: -1.80

Miscellaneous

• Outstanding Shares: 196,630,000
• Free Float: 154,042,000
• Market Cap: $70.92 million
• Optionable: Not Optionable
• Beta: -0.86